Sweden· SE-20160323000010
Cimzia 200 mg Injektionsvätska, lösning i förfylld injektionspenna
A medicinal product containing certolizumab pegol, registered in Sweden by UCB Pharma S.A..
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Certolizumab Pegol
- Manufacturer
- UCB Pharma S.A.
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20160323000010
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Certolizumab pegol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaCIMZIAUCB Pharma SA, Brusel
- SpainCIMZIA 200 MG SOLUCION INYECTABLE EN CARTUCHO PARA DISPENSADOR DE DOSISUcb Pharma
- IcelandCimziaUCB Pharma S.A.*
- BelgiumCimzia 200 mgUCB Pharma
- United KingdomCimzia 200mg/1ml solution for injection in a dose-dispenser cartridgeUCB Pharma Ltd
- NorwayCimziaUCB Pharma S.A. (2)
- PolandCimziaUCB Pharma S.A.
- FinlandCimziaParanova Oy
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Cimzia
- Liechtenstein · Cimzia
- Norway · Cimzia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e4e13449-07ca-4abe-85a4-7a0adb7a9ddf GET /v1/drugs/e4e13449-07ca-4abe-85a4-7a0adb7a9ddf?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20160323000010",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20160323000010",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/cimzia"
}See everything about certolizumab pegol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.